Intraoperative Nasal Insulin Effect on Plasma and CSF Insulin Concentration and Blood Glucose
Ischemic Heart Disease, Aortic Aneurysm
About this trial
This is an interventional basic science trial for Ischemic Heart Disease focused on measuring Intranasal Insulin, Insulin concentration, Blood glucose, Cerebro Spinal Fluid insulin, Intraoperative blood glucose, Cardiac Surgery, Thoracic Surgery
Eligibility Criteria
Inclusion Criteria:
All patients (>18 years) undergoing elective open heart surgery requiring CPB or elective endovascular thoracic aortic aneurysm repair at the RVH.
Exclusion Criteria:
- Planned use of drugs that effect plasma glucose concentration during the first four hours of surgery.
- Patients with allergy to insulin
- Patients with a base line blood glucose less than 3.9 mmol/L
Sites / Locations
- Royal Victoria Hospital McGill University Health CentreRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Experimental
Placebo Comparator
Intranasal 40
Intranasal 80
Placebo
Patients will receive 40 IU of intranasal insulin (Humulin R) via a metered nasal dispenser
Patients will receive 80 IU of intranasal insulin (Humulin R) via a metered nasal dispenser
Patients will receive intranasal normal saline via a metered nasal dispenser